BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 31900408)

  • 1. De novo generation of hit-like molecules from gene expression signatures using artificial intelligence.
    Méndez-Lucio O; Baillif B; Clevert DA; Rouquié D; Wichard J
    Nat Commun; 2020 Jan; 11(1):10. PubMed ID: 31900408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo generation of dual-target ligands using adversarial training and reinforcement learning.
    Lu F; Li M; Min X; Li C; Zeng X
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34410338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graph-based generative models for de Novo drug design.
    Xia X; Hu J; Wang Y; Zhang L; Liu Z
    Drug Discov Today Technol; 2019 Dec; 32-33():45-53. PubMed ID: 33386094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in de Novo Drug Design: From Conventional to Machine Learning Methods.
    Mouchlis VD; Afantitis A; Serra A; Fratello M; Papadiamantis AG; Aidinis V; Lynch I; Greco D; Melagraki G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De Novo Peptide and Protein Design Using Generative Adversarial Networks: An Update.
    Lin E; Lin CH; Lane HY
    J Chem Inf Model; 2022 Feb; 62(4):761-774. PubMed ID: 35128926
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Domenico A; Nicola G; Daniela T; Fulvio C; Nicola A; Orazio N
    J Chem Inf Model; 2020 Oct; 60(10):4582-4593. PubMed ID: 32845150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico.
    Kadurin A; Nikolenko S; Khrabrov K; Aliper A; Zhavoronkov A
    Mol Pharm; 2017 Sep; 14(9):3098-3104. PubMed ID: 28703000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry.
    Kao PY; Yang YC; Chiang WY; Hsiao JY; Cao Y; Aliper A; Ren F; Aspuru-Guzik A; Zhavoronkov A; Hsieh MH; Lin YC
    J Chem Inf Model; 2023 Jun; 63(11):3307-3318. PubMed ID: 37171372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generative Models for De Novo Drug Design.
    Tong X; Liu X; Tan X; Li X; Jiang J; Xiong Z; Xu T; Jiang H; Qiao N; Zheng M
    J Med Chem; 2021 Oct; 64(19):14011-14027. PubMed ID: 34533311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generative machine learning for de novo drug discovery: A systematic review.
    Martinelli DD
    Comput Biol Med; 2022 Jun; 145():105403. PubMed ID: 35339849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo drug design.
    Hartenfeller M; Schneider G
    Methods Mol Biol; 2011; 672():299-323. PubMed ID: 20838974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The convergence of artificial intelligence and chemistry for improved drug discovery.
    Green CP; Engkvist O; Pairaudeau G
    Future Med Chem; 2018 Nov; 10(22):2573-2576. PubMed ID: 30499699
    [No Abstract]   [Full Text] [Related]  

  • 13. Generative Deep Learning for Targeted Compound Design.
    Sousa T; Correia J; Pereira V; Rocha M
    J Chem Inf Model; 2021 Nov; 61(11):5343-5361. PubMed ID: 34699719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular
    Lin E; Lin CH; Lane HY
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32708785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generative Recurrent Networks for De Novo Drug Design.
    Gupta A; Müller AT; Huisman BJH; Fuchs JA; Schneider P; Schneider G
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29095571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep Learning Applied to Ligand-Based De Novo Drug Design.
    Palazzesi F; Pozzan A
    Methods Mol Biol; 2022; 2390():273-299. PubMed ID: 34731474
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Grisoni F; Schneider G
    Chimia (Aarau); 2019 Dec; 73(12):1006-1011. PubMed ID: 31883552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated De Novo Design in Medicinal Chemistry: Which Types of Chemistry Does a Generative Neural Network Learn?
    Grebner C; Matter H; Plowright AT; Hessler G
    J Med Chem; 2020 Aug; 63(16):8809-8823. PubMed ID: 32134646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities.
    Gangwal A; Ansari A; Ahmad I; Azad AK; Kumarasamy V; Subramaniyan V; Wong LS
    Front Pharmacol; 2024; 15():1331062. PubMed ID: 38384298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep Generative Models in
    Pang C; Qiao J; Zeng X; Zou Q; Wei L
    J Chem Inf Model; 2024 Apr; 64(7):2174-2194. PubMed ID: 37934070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.